Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles.

作者: Ole Terland , Torgeir Flatmark

DOI: 10.1016/S0028-3908(98)00233-0

关键词:

摘要: Abstract Cinnarizine (1-diphenylmethyl-4-(3-phenyl-2-propenyl)piperazine) and its di-fluorinated derivative flunarizine inhibit theMgATP-dependent generation of a transmembrane proton electrochemical gradient in chromaffine granule ghosts. The concentra-tions giving 50% inhibition (IC 50 ) the MgATP-dependent pH-gradient were 5.990.6 mM( n ˚6) 3.090.3mM( ˚5) for cinnarizine flunarizine, respectively. IC values inhibiting membrane potentialwere even lower, i.e. 0.1990.06 0.1590.01 ˚4) Cinnarizine(10 mM) also inhibited energy-dependent vesicular uptake [ 14 C]-dopamine (50 by 76%, from 2.190.9 to 0.5 90.6nmol:mg protein:min ( ˚5, P B0.002). (10 increased MgATPase activity ghosts 47926%( compatible with an uncoupling vacuolar H ˙ -ATPase activity. -values observed two compounds arein same range as their reported therapeutic plasma concentrations vivo, suggesting that may wellinhibit pumping catecholamine storage vesicles vivo. This mechanism action contribute tothe drug-induced parkinsonism seen side-effect drugs. © 1999 Elsevier Science Ltd. All rights reserved.

参考文章(27)
Kazuto Okimoto, Roger A Rajewski, Kaneto Uekama, Janan A Jona, Valentino J Stella, None, The Interaction of Charged and Uncharged Drugs with Neutral (HP-β-CD) and Anionically Charged (SBE7-β-CD) β-Cyclodextrins Pharmaceutical Research. ,vol. 13, pp. 256- 264 ,(1996) , 10.1023/A:1016047215907
Vargas-Alvarado Y, Aguirre F, Flores-Murrieta Fj, Castañeda-Hernández G, Pharmacokinetics of cinnarizine after single and multiple dosing in healthy volunteers. Drug Research. ,vol. 43, pp. 539- 542 ,(1993)
D. Peter, J. Jimenez, Y. Liu, J. Kim, R.H. Edwards, The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. Journal of Biological Chemistry. ,vol. 269, pp. 7231- 7237 ,(1994) , 10.1016/S0021-9258(17)37272-1
Andrea Vaccari, PierLuigi Saba, GianLuigi Gessa, Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine Neurochemical Research. ,vol. 18, pp. 1125- 1130 ,(1993) , 10.1007/BF00978362
T. Brücke, Ch. Wöber, I. Podreka, C. Wöber-Bingöl, S. Asenbaum, S. Aull, S. Wenger, D. Ilieva, C. Harasko van der Meer, P. Wessely, L. Deecke, D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study. Journal of Cerebral Blood Flow and Metabolism. ,vol. 15, pp. 513- 518 ,(1995) , 10.1038/JCBFM.1995.63
P. J. García Ruiz, M. A. Mena, N. Peñafiel, J. G. De Yébenes, Cinnarizine-induced parkinsonism in primates Clinical Neuropharmacology. ,vol. 15, pp. 152- 154 ,(1992) , 10.1097/00002826-199204000-00010
Torgeir Flatmark, Martin Grønberg, Eystein Husebye, Sissel Vik Berge, Inhibition by N-ethylmaleimide of the MgATP-driven proton pump of the chromaffin granules FEBS Letters. ,vol. 149, pp. 71- 74 ,(1982) , 10.1016/0014-5793(82)81074-0
C.G Clough, Parkinson's disease: management. The Lancet. ,vol. 337, pp. 1324- 1327 ,(1991) , 10.1016/0140-6736(91)92990-J